» Articles » PMID: 24166498

MicroRNAs, MiR-154, MiR-299-5p, MiR-376a, MiR-376c, MiR-377, MiR-381, MiR-487b, MiR-485-3p, MiR-495 and MiR-654-3p, Mapped to the 14q32.31 Locus, Regulate Proliferation, Apoptosis, Migration and Invasion in Metastatic Prostate Cancer Cells

Overview
Journal Oncogene
Date 2013 Oct 30
PMID 24166498
Citations 173
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs act as oncogenes or tumor suppressors in a wide variety of human cancers, including prostate cancer (PCa). We found a severe and consistent downregulation of miRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 region in metastatic cell lines as compared with normal prostatic epithelial cells (PrEC). In specimens of human prostate (28 normals, 99 primary tumors and 13 metastases), lower miRNA levels correlated significantly with a higher incidence of metastatic events and higher prostate specific antigen (PSA) levels, with similar trends observed for lymph node invasion and the Gleason score. We transiently transfected 10 members of the 14q32.31 cluster in normal prostatic epithelial cell lines and characterized their affect on malignant cell behaviors, including proliferation, apoptosis, migration and invasion. Finally, we identified FZD4, a gene important for epithelial-to-mesenchymal transition in (PCa), as a target of miR-377.

Citing Articles

MiRNA signature analysis in LSCC gene expression profiles indicates hsa-miR-299-5p as a new tumor suppressor.

Janiszewska J, Paczkowska J, Kostrzewska-Poczekaj M, Schreiber A, Kiwerska K, Bednarek K J Appl Genet. 2025; .

PMID: 40025000 DOI: 10.1007/s13353-025-00942-y.


ELABELA promotes the migration and homing of bone marrow mesenchymal stem cells to myocardial injury sites through the ERK1/2/miR-299a-5p/Exo70 pathway.

Hou J, Wu H, Li S, Li X, Yang S, Chen X Front Pharmacol. 2025; 16:1541869.

PMID: 39963243 PMC: 11831049. DOI: 10.3389/fphar.2025.1541869.


Reciprocal regulation between DNMT3A/3B and microRNAs miRs-299-3p/-30e is a causal factor for the downregulation of microRNAs targeting androgen receptor in prostate cancer.

Ganapathy K, Harrs C, Harris S, Staklinski S, Khatib A, Park J Heliyon. 2025; 11(3):e41948.

PMID: 39944334 PMC: 11815930. DOI: 10.1016/j.heliyon.2025.e41948.


Prostate cancer genotyping for risk stratification and precision treatment.

Kumar A Curr Urol. 2024; 18(2):87-97.

PMID: 39176294 PMC: 11337998. DOI: 10.1097/CU9.0000000000000222.


MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response.

Micheva I, Atanasova S Front Oncol. 2024; 14:1410656.

PMID: 39156702 PMC: 11327013. DOI: 10.3389/fonc.2024.1410656.